GC Biopharma and Speragen Sponsored an Externally Led - Patient Focused Drug Development with FDA Attendance ...Middle East

YONGIN, South Korea and AUSTIN, Texas, Aug. 30 2022 /PRNewswire/ -- GC Biopharma (006280.KS) and Speragen today announced that a joint Externally Led - Patient-Focused Drug Development (EL-PFDD) meeting hosted by SSADH Association and attended by the U.S. FDA and other stakeholders was...

Read More Details
Finally We wish PressBee provided you with enough information of ( GC Biopharma and Speragen Sponsored an Externally Led - Patient Focused Drug Development with FDA Attendance )

Also on site :

• Iconic ‘80s Actor, 76, Is Unrecognizable Nearly 35 Years After 'Dallas’
• Trump announces new round of US-China trade talks
• 'Days of Our Lives' Star, 53, Makes Plea to Fans Ahead of John Black's Funeral